Incidence of dyspnea and hyperventilation syndrome after COVID-19
W. MADI (Gabes, Tunisia), S. Mejdoub Fehri (Gabes, Tunisia), R. Sellami (Gabes, Tunisia), A. Eleuch (Gabes, Tunisia), R. Ammar (Gabes, Tunisia), I. Ketata (Gabes, Tunisia), H. Kwas (Gabes, Tunisia)
Source: International Congress 2022 – Miscellaneous: biomarkers for the management of chronic lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. MADI (Gabes, Tunisia), S. Mejdoub Fehri (Gabes, Tunisia), R. Sellami (Gabes, Tunisia), A. Eleuch (Gabes, Tunisia), R. Ammar (Gabes, Tunisia), I. Ketata (Gabes, Tunisia), H. Kwas (Gabes, Tunisia). Incidence of dyspnea and hyperventilation syndrome after COVID-19. 234
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|